MoneyWorks4Me

Lupin informs about investor presentation

07 Nov 2019 Evaluate

Lupin has informed that pursuant to Regulation 30(2) read with Schedule Ill Part A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed is a copy of the Q2 FY2020 Investor Presentation.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..